BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

449 related articles for article (PubMed ID: 24737733)

  • 1. Cancer stem cell-specific scavenger receptor CD36 drives glioblastoma progression.
    Hale JS; Otvos B; Sinyuk M; Alvarado AG; Hitomi M; Stoltz K; Wu Q; Flavahan W; Levison B; Johansen ML; Schmitt D; Neltner JM; Huang P; Ren B; Sloan AE; Silverstein RL; Gladson CL; DiDonato JA; Brown JM; McIntyre T; Hazen SL; Horbinski C; Rich JN; Lathia JD
    Stem Cells; 2014 Jul; 32(7):1746-58. PubMed ID: 24737733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct in vivo evidence for tumor propagation by glioblastoma cancer stem cells.
    Lathia JD; Gallagher J; Myers JT; Li M; Vasanji A; McLendon RE; Hjelmeland AB; Huang AY; Rich JN
    PLoS One; 2011; 6(9):e24807. PubMed ID: 21961046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered lipid metabolism marks glioblastoma stem and non-stem cells in separate tumor niches.
    Shakya S; Gromovsky AD; Hale JS; Knudsen AM; Prager B; Wallace LC; Penalva LOF; Brown HA; Kristensen BW; Rich JN; Lathia JD; Brown JM; Hubert CG
    Acta Neuropathol Commun; 2021 May; 9(1):101. PubMed ID: 34059134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain tumor stem cells from an adenoid glioblastoma multiforme.
    Oka N; Soeda A; Noda S; Iwama T
    Neurol Med Chir (Tokyo); 2009 Apr; 49(4):146-50; discussion 150-1. PubMed ID: 19398857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Native and modified low density lipoproteins increase the functional expression of the macrophage class B scavenger receptor, CD36.
    Han J; Hajjar DP; Febbraio M; Nicholson AC
    J Biol Chem; 1997 Aug; 272(34):21654-9. PubMed ID: 9261189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coordination of self-renewal in glioblastoma by integration of adhesion and microRNA signaling.
    Alvarado AG; Turaga SM; Sathyan P; Mulkearns-Hubert EE; Otvos B; Silver DJ; Hale JS; Flavahan WA; Zinn PO; Sinyuk M; Li M; Guda MR; Velpula KK; Tsung AJ; Nakano I; Vogelbaum MA; Majumder S; Rich JN; Lathia JD
    Neuro Oncol; 2016 May; 18(5):656-66. PubMed ID: 26374689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gliomasphere marker combinatorics: multidimensional flow cytometry detects CD44+/CD133+/ITGA6+/CD36+ signature.
    Erhart F; Blauensteiner B; Zirkovits G; Printz D; Soukup K; Klingenbrunner S; Fischhuber K; Reitermaier R; Halfmann A; Lötsch D; Spiegl-Kreinecker S; Berger W; Visus C; Dohnal A
    J Cell Mol Med; 2019 Jan; 23(1):281-292. PubMed ID: 30467961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identifying conserved molecular targets required for cell migration of glioblastoma cancer stem cells.
    Volovetz J; Berezovsky AD; Alban T; Chen Y; Lauko A; Aranjuez GF; Burtscher A; Shibuya K; Silver DJ; Peterson J; Manor D; McDonald JA; Lathia JD
    Cell Death Dis; 2020 Feb; 11(2):152. PubMed ID: 32102991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pyrvinium Targets CD133 in Human Glioblastoma Brain Tumor-Initiating Cells.
    Venugopal C; Hallett R; Vora P; Manoranjan B; Mahendram S; Qazi MA; McFarlane N; Subapanditha M; Nolte SM; Singh M; Bakhshinyan D; Garg N; Vijayakumar T; Lach B; Provias JP; Reddy K; Murty NK; Doble BW; Bhatia M; Hassell JA; Singh SK
    Clin Cancer Res; 2015 Dec; 21(23):5324-37. PubMed ID: 26152745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sox2, a stemness gene, regulates tumor-initiating and drug-resistant properties in CD133-positive glioblastoma stem cells.
    Song WS; Yang YP; Huang CS; Lu KH; Liu WH; Wu WW; Lee YY; Lo WL; Lee SD; Chen YW; Huang PI; Chen MT
    J Chin Med Assoc; 2016 Oct; 79(10):538-45. PubMed ID: 27530866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxidized Low-Density Lipoprotein Links Hypercholesterolemia and Bladder Cancer Aggressiveness by Promoting Cancer Stemness.
    Yang L; Sun J; Li M; Long Y; Zhang D; Guo H; Huang R; Yan J
    Cancer Res; 2021 Nov; 81(22):5720-5732. PubMed ID: 34479964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TGFβ-Responsive HMOX1 Expression Is Associated with Stemness and Invasion in Glioblastoma Multiforme.
    Ghosh D; Ulasov IV; Chen L; Harkins LE; Wallenborg K; Hothi P; Rostad S; Hood L; Cobbs CS
    Stem Cells; 2016 Sep; 34(9):2276-89. PubMed ID: 27354342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sox2 promotes malignancy in glioblastoma by regulating plasticity and astrocytic differentiation.
    Berezovsky AD; Poisson LM; Cherba D; Webb CP; Transou AD; Lemke NW; Hong X; Hasselbach LA; Irtenkauf SM; Mikkelsen T; deCarvalho AC
    Neoplasia; 2014 Mar; 16(3):193-206, 206.e19-25. PubMed ID: 24726753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of cancer stem cells from human glioblastomas: growth and differentiation capabilities and CD133/prominin-1 expression.
    Gambelli F; Sasdelli F; Manini I; Gambarana C; Oliveri G; Miracco C; Sorrentino V
    Cell Biol Int; 2012 Jan; 36(1):29-38. PubMed ID: 21916848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of CXCL12/CXCR4 autocrine/paracrine loop reduces viability of human glioblastoma stem-like cells affecting self-renewal activity.
    Gatti M; Pattarozzi A; Bajetto A; Würth R; Daga A; Fiaschi P; Zona G; Florio T; Barbieri F
    Toxicology; 2013 Dec; 314(2-3):209-20. PubMed ID: 24157575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer Stem Cell-Secreted Macrophage Migration Inhibitory Factor Stimulates Myeloid Derived Suppressor Cell Function and Facilitates Glioblastoma Immune Evasion.
    Otvos B; Silver DJ; Mulkearns-Hubert EE; Alvarado AG; Turaga SM; Sorensen MD; Rayman P; Flavahan WA; Hale JS; Stoltz K; Sinyuk M; Wu Q; Jarrar A; Kim SH; Fox PL; Nakano I; Rich JN; Ransohoff RM; Finke J; Kristensen BW; Vogelbaum MA; Lathia JD
    Stem Cells; 2016 Aug; 34(8):2026-39. PubMed ID: 27145382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer stem cells from human glioblastoma resemble but do not mimic original tumors after in vitro passaging in serum-free media.
    García-Romero N; González-Tejedo C; Carrión-Navarro J; Esteban-Rubio S; Rackov G; Rodríguez-Fanjul V; Oliver-De La Cruz J; Prat-Acín R; Peris-Celda M; Blesa D; Ramírez-Jiménez L; Sánchez-Gómez P; Perona R; Escobedo-Lucea C; Belda-Iniesta C; Ayuso-Sacido A
    Oncotarget; 2016 Oct; 7(40):65888-65901. PubMed ID: 27589567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteins of the Wnt signaling pathway as targets for the regulation of CD133+ cancer stem cells in glioblastoma.
    Shevchenko V; Arnotskaya N; Korneyko M; Zaytsev S; Khotimchenko Y; Sharma H; Bryukhovetskiy I
    Oncol Rep; 2019 May; 41(5):3080-3088. PubMed ID: 30864699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extracellular vesicle-mediated transfer of CLIC1 protein is a novel mechanism for the regulation of glioblastoma growth.
    Setti M; Osti D; Richichi C; Ortensi B; Del Bene M; Fornasari L; Beznoussenko G; Mironov A; Rappa G; Cuomo A; Faretta M; Bonaldi T; Lorico A; Pelicci G
    Oncotarget; 2015 Oct; 6(31):31413-27. PubMed ID: 26429879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. B7-H4(B7x)-Mediated Cross-talk between Glioma-Initiating Cells and Macrophages via the IL6/JAK/STAT3 Pathway Lead to Poor Prognosis in Glioma Patients.
    Yao Y; Ye H; Qi Z; Mo L; Yue Q; Baral A; Hoon DSB; Vera JC; Heiss JD; Chen CC; Zhang J; Jin K; Wang Y; Zang X; Mao Y; Zhou L
    Clin Cancer Res; 2016 Jun; 22(11):2778-2790. PubMed ID: 27001312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.